Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Solventum Corp. (SOLV)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: SOLV (2-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
12 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $86.25
1 Year Target Price $86.25
| 1 | Strong Buy |
| 2 | Buy |
| 8 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 9.8% | Avg. Invested days 55 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 12.85B USD | Price to earnings Ratio 34 | 1Y Target Price 86.25 |
Price to earnings Ratio 34 | 1Y Target Price 86.25 | ||
Volume (30-day avg) 12 | Beta - | 52 Weeks Range 60.70 - 85.92 | Updated Date 09/17/2025 |
52 Weeks Range 60.70 - 85.92 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.18 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 4.53% | Operating Margin (TTM) 9.26% |
Management Effectiveness
Return on Assets (TTM) 3.52% | Return on Equity (TTM) 11.67% |
Valuation
Trailing PE 34 | Forward PE 12.05 | Enterprise Value 20176237465 | Price to Sales(TTM) 1.53 |
Enterprise Value 20176237465 | Price to Sales(TTM) 1.53 | ||
Enterprise Value to Revenue 2.41 | Enterprise Value to EBITDA 15.81 | Shares Outstanding 173387798 | Shares Floating 147464588 |
Shares Outstanding 173387798 | Shares Floating 147464588 | ||
Percent Insiders 14.9 | Percent Institutions 66.71 |
Upturn AI SWOT
Solventum Corp.
Company Overview
History and Background
Solventum Corp. was spun off from 3M in April 2024. Its history is intertwined with 3M's healthcare division, focusing on medical solutions.
Core Business Areas
- Medical Solutions: Wound care, sterilization, and infection prevention solutions aimed at hospitals and healthcare providers.
- Oral Care Solutions: Dental and orthodontic products, including restoratives, adhesives, and aligners for dental professionals.
- Health Information Systems: Software and services for healthcare data management, analytics, and patient engagement.
- Purification and Filtration: Provides solutions for the biopharma industry.
Leadership and Structure
Details on the current leadership team and organizational structure can be found on the company's investor relations website. Information is evolving post-spinoff.
Top Products and Market Share
Key Offerings
- Revenue: Unknown: Solventum Corp. began trading in 2024 and detailed breakdown is unavailable for the new entity.
- Wound Care Dressings: Advanced wound care products; market share varies by specific dressing type. Competitors include Smith & Nephew (SNN), Convatec Group (CTEC), and Molnlycke Health Care.
- Dental Adhesives and Restoratives: Dental adhesives and restorative materials for dental procedures; competition from Dentsply Sirona (XRAY), Envista Holdings Corporation (NVST), and Ivoclar Vivadent.
- Revenue: Unknown: Solventum Corp. began trading in 2024 and detailed breakdown is unavailable for the new entity.
- Revenue: Unknown: Solventum Corp. began trading in 2024 and detailed breakdown is unavailable for the new entity.
- Sterilization Indicators: Chemical indicators and biological indicators for sterilization monitoring; market share dependent on region. Competitors include Cantel Medical (now part of STERIS (STE)) and Getinge (GETI-B.ST).
Market Dynamics
Industry Overview
The healthcare industry is experiencing growth driven by an aging population, increasing chronic diseases, and technological advancements. Regulatory pressures and cost containment efforts are also significant factors.
Positioning
Solventum Corp. aims to be a leading provider of healthcare solutions with a focus on innovation and quality. Its competitive advantage lies in its established brand name (previously 3M), extensive product portfolio, and global distribution network. The company is attempting to transform into a independent business.
Total Addressable Market (TAM)
The TAM encompasses several sub-segments, including medical devices, dental products, and healthcare IT. These markets are estimated in the hundreds of billions of dollars globally. Solventum's TAM includes large portions of these markets.
Upturn SWOT Analysis
Strengths
- Strong brand recognition (associated with 3M)
- Extensive product portfolio
- Global distribution network
- Focus on innovation and R&D
- Experienced management team
Weaknesses
- Newly independent company with limited standalone track record
- Dependence on 3M for certain services (initially)
- Potential integration challenges post-spinoff
- Debt burden from the separation agreement
Opportunities
- Expanding into new markets (geographic and product-wise)
- Acquiring complementary businesses
- Developing innovative solutions for emerging healthcare needs
- Leveraging digital technologies for enhanced customer engagement
Threats
- Intense competition from established players
- Regulatory changes impacting healthcare products and services
- Economic downturn affecting healthcare spending
- Technological disruptions rendering existing products obsolete
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- JNJ
- BSX
- BDX
- DHR
- XRAY
- NVST
- STE
Competitive Landscape
Solventum faces competition from larger, more diversified healthcare companies. To compete effectively, the company needs to focus on niche markets, innovative products, and superior customer service.
Growth Trajectory and Initiatives
Historical Growth: Historical data is tied to 3M's healthcare segment.
Future Projections: Analyst estimates will emerge as the company releases quarterly results. Growth will likely depend on innovation, market expansion, and strategic acquisitions.
Recent Initiatives: Spin-off from 3M, establishment of independent operations, cost optimization efforts, and investment in R&D.
Summary
Solventum Corp. is a newly formed entity spun off from 3M, bringing with it a strong foundation but also facing challenges inherent in establishing independence. Its established brand and product portfolio are strengths, but it must navigate integration and compete effectively. The company needs to focus on innovation and cost management to drive growth and deliver value to shareholders. The existing debt could be a major burden that the company needs to service.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC filings, Investor Relations website, Analyst reports (when available), Market research reports
Disclaimers:
The information provided is for informational purposes only and should not be considered as financial advice. Investment decisions should be made based on individual circumstances and consultation with a qualified financial advisor. Market share data is estimated and may not be precise. This is a new stock with a very short period of market information available.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Solventum Corp.
Exchange NYSE | Headquaters Maplewood, MN, United States | ||
IPO Launch date 2024-03-26 | CEO & Director Mr. Bryan C. Hanson | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 22000 | Website https://www.solventum.com |
Full time employees 22000 | Website https://www.solventum.com | ||
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wrap, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. Its Purification and Filtration segment provides purification and filtration technologies comprising filters, purifiers, cartridges, and membranes. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.